by Vora Corporate Finance | May 21, 2021 | Financial Advisory, Insights, Merger & Acquisitions
Transaction: Piramal Pharma Limited to acquire a 100% stake in Hemmo Pharmaceuticals Pvt. Ltd. for an upfront consideration of Rs.775 crores and earn-outs linked to achievement of milestones. Consequent to this acquisition, Hemmo will become a wholly owned subsidiary...
by Vora Corporate Finance | May 20, 2021 | Financial Advisory, Insights, Private Equity & IPO
Transaction: Creador sold its stake in Ahmedabad based Corona Remedies to PE fund ChrysCapital. ChrysCapital paid Rs.6.7 billion ($90 million) for a 30% stake, of which 20% came from Creador and 10% from the promoter group. The deal values Corona Remedies at around...
by Vora Corporate Finance | May 18, 2021 | Financial Advisory, Insights, Merger & Acquisitions
Transaction: BYJU’S has announced to acquire Aakash Educational Services Limited (AESL) through a strategic merger in a nearly $1 Billion deal. Aakash founders JC Chaudhry and Aakash Chaudhry will continue to lead AESL’s growth and expansion. Aakash founders along...
by Vora Corporate Finance | May 18, 2021 | Articles, Capital Market Updates, Debt Syndication, Merger & Acquisitions, Private Equity & IPO
Capital Market quarterly update of Q4 FY21 published in the ACAE Kolkata (Association of Corporate Advisors & Executives) Journal in April 2021. The new year 2021 has begun on a strong positive note with vaccination drives in major economies as well as in India....
by Vora Corporate Finance | Jan 25, 2021 | Insights
Indian Economy is pulling out of Covid-19’s impact and recovering at a pace that beats most predictions as per RBI Report. Estimated GDP growth in Q3 is likely to be positive 0.1%. The manufacturing and services purchasing managers’ index (PMI) at 56.3 and 53.7...
